Association of treatment-emergent symptoms identified by patient-reported outcomes with adjuvant endocrine therapy discontinuation

Association of treatment-emergent symptoms identified by patient-reported outcomes with adjuvant endocrine therapy discontinuation

Many patients discontinue endocrine therapy for breast cancer due to intolerance. Identification of patients at risk for discontinuation is challenging. The minimal important difference (MID) is the smallest change in a score on a patient-reported outcome (PRO) that is clinically significant. We eva...

Full description

Bibliographic Details
Main Authors: Armstrong, D.K (Author), Blackford, A.L (Author), Connolly, R. (Author), Fetting, J. (Author), Jelovac, D. (Author), Lehman, J. (Author), Lim, D. (Author), Miller, R.S (Author), Nunes, R. (Author), Papathakis, K. (Author), Riley, C. (Author), Sheng, J.Y (Author), Smith, K.L (Author), Snyder, C. (Author), Stearns, V. (Author), Verma, N. (Author), Visvanathan, K. (Author), Westbrook, K. (Author), Wolff, A.C (Author), Zafman, N. (Author)
Format: Article
Language:English
Published: Nature Research 2022
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items